Second Line Treatment Patterns After First Line Immunotherapy In Hcc

Summary

Julien Edeline, MD, PhD, Centre Eugene Marquis, Rennes, France, discusses real-world data from the CHIEF cohort, which ... In this video expert, Dr Timon Vandamme, discusses reviewing the outcomes in Ghassan K. Abou-Alfa, MD, discusses the rationale for using regorafenib in a patient with metastatic Assoc. Prof. Gerald Prager reviews two key abstracts on rectal cancer presented at ASCO 2023: PRODIGE 23 and PROSPECT ... Editor's note: Recently, the combined Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Republic of Korea, discusses the results of a multinational, multicenter, ... Stephen Lam Chan, MD, FRCP, Chinese University of Hong Kong, Hong Kong, China, presents final analysis results from the ... Lipika Goyal, MD, a hematologist and medical oncologist at Massachusetts General Hospital, discusses Arndt Vogel, MD, PhD, Hannover Medical School, Hannover, Germany, discusses the Phase II KEYNOTE-224 trial ... Panelists Richard S. Finn, MD; Jordi Bruix, MD; and Richard H. Marshall, MD, review the results from the RESORCE clinical trial ... Josep M. Llovet, MD, PhD, founder and director of the Liver Cancer Program at Mount Sinai School of Medicine and professor at ... Tanios S. Bekaii-Saab, MD, FACP, discusses This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...